{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:09:51Z","timestamp":1791407391219,"version":"4.3.3"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T00:00:00Z","timestamp":1650412800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000025","name":"NIMH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006190","name":"VA Office of Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006190","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.eclinm.2022.101439","type":"journal-article","created":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T01:37:41Z","timestamp":1651801061000},"page":"101439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Effects of intranasal (S)-ketamine on Veterans with co-morbid treatment-resistant depression and PTSD: A retrospective case series"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1564-4151","authenticated-orcid":false,"given":"Hewa","family":"Artin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Bentley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eamonn","family":"Mehaffey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred X.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Sojourner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew W.","family":"Bismark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Printz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen E.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Martis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"De Peralta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dewleen G.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5212-3067","authenticated-orcid":false,"given":"Dhakshin","family":"Ramanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2022.101439_bib0001","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.janxdis.2015.02.003","article-title":"The prevalence of posttraumatic stress disorder in operation enduring freedom\/operation Iraqi freedom (OEF\/OIF) Veterans: a meta-analysis","volume":"31","author":"Fulton","year":"2015","journal-title":"J Anxiety Disord"},{"key":"10.1016\/j.eclinm.2022.101439_bib0002","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jad.2009.12.005","article-title":"Comorbidity of PTSD and depression in Korean war Veterans: prevalence, predictors, and impairment","volume":"125","author":"Ikin","year":"2010","journal-title":"J Affect Disord"},{"key":"10.1016\/j.eclinm.2022.101439_bib0003","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.neuropharm.2011.06.012","article-title":"Pharmacological treatment of PTSD \u2013 established and new approaches","volume":"62","author":"Steckler","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.eclinm.2022.101439_bib0004","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1001\/jama.2015.8370","article-title":"Psychotherapy for military-related PTSD: a review of randomized clinical trials","volume":"314","author":"Steenkamp","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.eclinm.2022.101439_bib0005","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1001\/jama.2019.20825","article-title":"First-line psychotherapies for military-related PTSD","volume":"323","author":"Steenkamp","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.eclinm.2022.101439_bib0006","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.pnpbp.2008.12.004","article-title":"Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: a systematic review","volume":"33","author":"Berger","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.eclinm.2022.101439_bib0007","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/j.biopsych.2017.03.007","article-title":"It is time to address the crisis in the pharmacotherapy of posttraumatic stress disorder: a consensus statement of the PTSD psychopharmacology working group","volume":"82","author":"Krystal","year":"2017","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.eclinm.2022.101439_bib0008","series-title":"Polypharmacy in Psychiatry","first-page":"151","article-title":"Polypharmacy of posttraumatic stress disorder","author":"Banks","year":"2002"},{"key":"10.1016\/j.eclinm.2022.101439_bib0009","article-title":"Accumulation of good intentions: how individual practice guidelines lead to polypharmacy in the treatment of patients with polytrauma","author":"Brown-Taylor","year":"2020","journal-title":"PM R"},{"key":"10.1016\/j.eclinm.2022.101439_bib0010","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1001\/archpsyc.1995.03950240066012","article-title":"Posttraumatic stress disorder in the national comorbidity survey","volume":"52","author":"Kessler","year":"1995","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.eclinm.2022.101439_bib0011","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/jts.21814","article-title":"The co-occurrence of major depressive disorder among individuals with posttraumatic stress disorder: a meta-analysis","volume":"26","author":"Rytwinski","year":"2013","journal-title":"J Trauma Stress"},{"key":"10.1016\/j.eclinm.2022.101439_bib0012","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.4088\/JCP.12m07844","article-title":"Co-occurrence of major depressive episode and posttraumatic stress disorder among survivors of war: how is it different from either condition alone?","volume":"74","author":"Morina","year":"2013","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.eclinm.2022.101439_bib0013","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/jts.21814","article-title":"The co-occurrence of major depressive disorder among individuals with posttraumatic stress disorder: a meta-analysis","volume":"26","author":"Rytwinski","year":"2013","journal-title":"J Trauma Stress"},{"key":"10.1016\/j.eclinm.2022.101439_bib0014","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1186\/s12888-019-2375-1","article-title":"Longitudinal trajectories of comorbid PTSD and depression symptoms among U.S. service members and veterans","volume":"19","author":"Armenta","year":"2019","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.eclinm.2022.101439_bib0015","doi-asserted-by":"crossref","first-page":"141","DOI":"10.31887\/DCNS.2015.17.2\/jflory","article-title":"Comorbidity between post-traumatic stress disorder and major depressive disorder: alternative explanations and treatment considerations","volume":"17","author":"Flory","year":"2015","journal-title":"Dialogues Clin Neurosci"},{"key":"10.1016\/j.eclinm.2022.101439_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2021.110410","article-title":"Classifying major mental disorders genetically","volume":"112","author":"Cao","year":"2022","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.eclinm.2022.101439_bib0017","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jad.2019.06.072","article-title":"Psychological burden of PTSD, depression, and their comorbidity in the U.S. Veteran population: suicidality, functioning, and service utilization","volume":"256","author":"Nichter","year":"2019","journal-title":"J Affect Disord"},{"key":"10.1016\/j.eclinm.2022.101439_bib0018","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jad.2019.06.039","article-title":"Conceptualizing comorbid PTSD and depression among treatment-seeking, active duty military service members","volume":"256","author":"Moring","year":"2019","journal-title":"J Affect Disord"},{"key":"10.1016\/j.eclinm.2022.101439_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.112631","article-title":"Ketamine's dose related multiple mechanisms of actions: dissociative anesthetic to rapid antidepressant","volume":"390","author":"Lavender","year":"2020","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.eclinm.2022.101439_bib0020","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.eclinm.2022.101439_bib0021","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1176\/appi.ajp.2013.13030392","article-title":"Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial","volume":"170","author":"Murrough","year":"2013","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.eclinm.2022.101439_bib0022","doi-asserted-by":"crossref","DOI":"10.1177\/2045125320916657","article-title":"Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers","volume":"10","author":"Matveychuk","year":"2020","journal-title":"Ther Adv Psychopharmacol"},{"key":"10.1016\/j.eclinm.2022.101439_bib0023","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.eclinm.2022.101439_bib0024","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1176\/appi.ajp.2018.17060720","article-title":"Efficacy and safety of intranasal esketamine for the rapid reduction of symptoms of depression and suicidality in patients at imminent risk for suicide: results of a double-blind, randomized, placebo-controlled study","volume":"175","author":"Canuso","year":"2018","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.eclinm.2022.101439_bib0025","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/jamapsychiatry.2017.3739","article-title":"Efficacy and safety of intranasal esketamine adjunctive to oral antidepressant therapy in treatment-resistant depression","volume":"75","author":"Daly","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.eclinm.2022.101439_bib0026","doi-asserted-by":"crossref","DOI":"10.7573\/dic.212305","article-title":"Ketamine as treatment for post-traumatic stress disorder: a review","volume":"8","author":"Liriano","year":"2019","journal-title":"Drugs Context"},{"key":"10.1016\/j.eclinm.2022.101439_bib0027","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/jamapsychiatry.2014.62","article-title":"Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial","volume":"71","author":"Feder","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.eclinm.2022.101439_bib0028","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1176\/appi.ajp.2020.20050596","article-title":"A randomized controlled trial of repeated ketamine administration for chronic posttraumatic stress disorder","volume":"178","author":"Feder","year":"2021","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.eclinm.2022.101439_bib0029","article-title":"Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial","author":"Abdallah","year":"2021","journal-title":"MedRxiv"},{"key":"10.1016\/j.eclinm.2022.101439_bib0030","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.17m11634","article-title":"Efficacy, safety, and durability of repeated ketamine infusions for comorbid posttraumatic stress disorder and treatment-resistant depression","volume":"79","author":"Albott","year":"2018","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.eclinm.2022.101439_bib0031","doi-asserted-by":"crossref","DOI":"10.1177\/2470547020980681","article-title":"Ketamine normalizes the structural alterations of inferior frontal gyrus in depression","volume":"4","author":"Dai","year":"2020","journal-title":"Chronic Stress"},{"key":"10.1016\/j.eclinm.2022.101439_bib0032","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/14656566.2019.1683161","article-title":"Efficacy and safety of intranasal esketamine for the treatment of major depressive disorder","volume":"21","author":"Kryst","year":"2020","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.eclinm.2022.101439_bib0033","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jad.2020.01.002","article-title":"Adjunctive intranasal esketamine for major depressive disorder: a systematic review of randomized double-blind controlled-placebo studies","volume":"265","author":"Zheng","year":"2020","journal-title":"J Affect Disord"},{"key":"10.1016\/j.eclinm.2022.101439_bib0034","article-title":"Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability","volume":"1\u201319","author":"Bonaventura","year":"2021","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.eclinm.2022.101439_bib0035","doi-asserted-by":"crossref","first-page":"e632","DOI":"10.1038\/tp.2015.136","article-title":"R -ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects","volume":"5","author":"Yang","year":"2015","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.eclinm.2022.101439_bib0036","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature17998","article-title":"NMDAR inhibition-independent antidepressant actions of ketamine metabolites","volume":"533","author":"Zanos","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.eclinm.2022.101439_bib0037","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/bdd.336","article-title":"Plasma concentration profiles of ketamine and norketamine after administration of various ketamine preparations to healthy Japanese volunteers","volume":"24","author":"Yanagihara","year":"2003","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.eclinm.2022.101439_bib0038","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jad.2015.12.075","article-title":"Validation of the PHQ-9 in a psychiatric sample","volume":"193","author":"Beard","year":"2016","journal-title":"J Affect Disord"},{"key":"10.1016\/j.eclinm.2022.101439_bib0039","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.jad.2021.07.108","article-title":"Performance of the PHQ-9 across conditions and comorbidities: findings from the Veterans outcome assessment survey","volume":"294","author":"Katz","year":"2021","journal-title":"J Affect Disord"},{"key":"10.1016\/j.eclinm.2022.101439_bib0040","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/jts.22059","article-title":"The posttraumatic stress disorder checklist for DSM-5 (PCL-5): development and initial psychometric evaluation","volume":"28","author":"Blevins","year":"2015","journal-title":"J Trauma Stress"},{"key":"10.1016\/j.eclinm.2022.101439_bib0041","article-title":"Dimensional structure of <em>DSM-5<\/em>posttraumatic stress disorder symptoms: results from the national health and resilience in Veterans study","volume":"76","author":"Tsai","year":"2014","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.eclinm.2022.101439_bib0042","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12874-017-0442-1","article-title":"When and how should multiple imputation be used for handling missing data in randomised clinical trials \u2013 a practical guide with flowcharts","volume":"17","author":"Jakobsen","year":"2017","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.eclinm.2022.101439_bib0043","volume":"281","author":"Hudgens","year":"2020","journal-title":"J Affect Disord"},{"key":"10.1016\/j.eclinm.2022.101439_bib0044","unstructured":"Monica, 1776 Main Street Santa & California 90401-3208. Improving the quality of mental health care for Veterans: Lessons from RAND Research. (2019). https:\/\/www.rand.org\/pubs\/research_briefs\/RB10087.html"},{"key":"10.1016\/j.eclinm.2022.101439_bib0045","doi-asserted-by":"crossref","first-page":"201","DOI":"10.5498\/wjp.v11.i6.201","article-title":"How do serotonergic psychedelics treat depression: the potential role of neuroplasticity","volume":"11","author":"Artin","year":"2021","journal-title":"World J Psychiatry"},{"key":"10.1016\/j.eclinm.2022.101439_bib0046","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pbb.2019.04.008","article-title":"Comparison of antidepressant and side effects in mice after intranasal administration of (R,S)-ketamine, (R)-ketamine, and (S)-ketamine","volume":"181","author":"Chang","year":"2019","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.eclinm.2022.101439_bib0047","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1176\/appi.ajp.2019.19040423","article-title":"A word to the wise about intranasal esketamine","volume":"176","author":"Schatzberg","year":"2019","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.eclinm.2022.101439_bib0048","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1038\/s41380-019-0503-4","article-title":"Attenuation of antidepressant and antisuicidal effects of ketamine by opioid receptor antagonism","volume":"24","author":"Williams","year":"2019","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.eclinm.2022.101439_bib0049","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1176\/appi.ajp.2018.18020138","article-title":"Attenuation of antidepressant effects of ketamine by opioid receptor antagonism","volume":"175","author":"Williams","year":"2018","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.eclinm.2022.101439_bib0050","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1073\/pnas.1916570117","article-title":"Opioid system is necessary but not sufficient for antidepressive actions of ketamine in rodents","volume":"117","author":"Klein","year":"2020","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.eclinm.2022.101439_bib0051","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature10130","article-title":"NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses","volume":"475","author":"Autry","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.eclinm.2022.101439_bib0052","article-title":"Sustained effects of rapidly acting antidepressants require BDNF-dependent MeCP2 phosphorylation","volume":"1\u201310","author":"Kim","year":"2021","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.eclinm.2022.101439_bib0053","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1124\/pharmrev.120.000149","article-title":"Hydroxynorketamines: pharmacology and potential therapeutic applications","volume":"73","author":"Highland","year":"2021","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.eclinm.2022.101439_bib0054","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/s41380-018-0028-2","article-title":"Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects","volume":"24","author":"Nugent","year":"2019","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.eclinm.2022.101439_bib0055","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/s41386-020-0663-6","article-title":"Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depression","volume":"45","author":"Farmer","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.eclinm.2022.101439_bib0056","doi-asserted-by":"crossref","DOI":"10.1126\/science.aat8078","article-title":"Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formation","volume":"364","author":"Moda-Sava","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.eclinm.2022.101439_bib0057","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature25509","article-title":"Ketamine blocks bursting in the lateral habenula to rapidly relieve depression","volume":"554","author":"Yang","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.eclinm.2022.101439_bib0058","article-title":"Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor","volume":"1\u201315","author":"Wei","year":"2021","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.eclinm.2022.101439_bib0059","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2016.12.026","article-title":"Ketamine accelerates fear extinction via mTORC1 signaling","volume":"100","author":"Girgenti","year":"2017","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.eclinm.2022.101439_bib0060","first-page":"261","article-title":"Chapter Nine - The emergence of ketamine as a novel treatment for posttraumatic stress disorder","volume":"89","author":"Feder","year":"2020"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537022001699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537022001699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T19:12:03Z","timestamp":1762888323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537022001699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":60,"alternative-id":["S2589537022001699"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2022.101439","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of intranasal (S)-ketamine on Veterans with co-morbid treatment-resistant depression and PTSD: A retrospective case series","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2022.101439","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101439"}}